222-N Analysis of pathologic features and efficacy outcomes with neoadjuvant nivolumab plus platinum-doublet chemotherapy for resectable non-small cell lung cancer in CheckMate 816

• Keith M Kerr,
• Elizabeth Thompson,
• Mariano Provencio,
• Patrick M Forde,
• Jaclyn Neely,
• Ashley Cimino-Mathews,
• Ludmila Danilova,
• Daphne Wang,
• Robert A Anders,
• Tricia R Cottrell,
• Nicolas Girard,
• Janis Taube,
• Peter Illei,
• Junliang Cai,
• Joel Sunshine,
• Julie Stein Deutsch,
• Jonathan Spicer,
• Edward Gabrielson,
• Jaroslaw Jedrych,
• Mia Tran,
• Judy Bushong,
• Vipul Devas,
• David Balli,
• Alex S Baras

Affiliations

Keith M Kerr

5Aberdeen Royal Infirmary, Aberdeen, UK

Elizabeth Thompson

1Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Mariano Provencio

2Hospital Universitario Puerta de Hierro, Madrid, Spain

Patrick M Forde

1Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Jaclyn Neely

6Bristol Myers Squibb, Princeton, NJ, USA

Ashley Cimino-Mathews

1Johns Hopkins University, Baltimore, MD, USA

Ludmila Danilova

1Johns Hopkins University School of Medicine, Baltimore, MD, USA

Daphne Wang

1 Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Robert A Anders

1Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Tricia R Cottrell

7Queen’s University, Kingston, Ontario, Canada

Nicolas Girard

4Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France

Janis Taube

1Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Peter Illei

1Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Junliang Cai

6Bristol Myers Squibb, Princeton, NJ, USA

Joel Sunshine

1Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Julie Stein Deutsch

1 Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Jonathan Spicer

3McGill University Health Center, Montreal, Québec, Canada

Edward Gabrielson

1Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Jaroslaw Jedrych

1Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Mia Tran

6Bristol Myers Squibb, Princeton, NJ, USA

Judy Bushong

6Bristol Myers Squibb, Princeton, NJ, USA

Vipul Devas

6Bristol Myers Squibb, Princeton, NJ, USA

David Balli

6Bristol Myers Squibb, Princeton, NJ, USA

Alex S Baras

1Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA